Summary
Signal counts
Assets tracked: 4
Watchlist assets: 3
Registry stop assets: 0
Sponsor overview
Sanofi
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT01882868 | https://clinicaltrials.gov/study/NCT01576029 | https://clinicaltrials.gov/study/NCT02812706 | https://clinicaltrials.gov/study/NCT00611962
Assets
Linked programs
- Aflibercept: Low Signal (1/5)
- CABAZITAXEL (XRP6258): Results Not Found Signal (2/5)
- Isatuximab SAR650984: Watchlist Signal (2/5)
- Oxaliplatin, Paclitaxel: Results Not Found Signal (2/5)